USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	063364/0710			Pages:	12
		Recorded:	04/15/2023
Attorney Dkt #:	17680-98
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 42

Patent #:	8026261	Issue Dt:	09/27/2011	Application #:	12078079	Filing Dt:	03/27/2008
Publication #:	US20080242706	Pub Dt:	10/02/2008
Title:	FLUORINATED DERIVATIVES OF DEFERIPRONE

Patent #:	8974816	Issue Dt:	03/10/2015	Application #:	12872447	Filing Dt:	08/31/2010
Publication #:	US20110059155	Pub Dt:	03/10/2011
Title:	WATER RESISTANT PATCH PREPARATION

Patent #:	8673943	Issue Dt:	03/18/2014	Application #:	13245262	Filing Dt:	09/26/2011
Publication #:	US20120095061	Pub Dt:	04/19/2012
Title:	FLUORINATED DERIVATIVES OF DEFERIPRONE

Patent #:	9073865	Issue Dt:	07/07/2015	Application #:	13382130	Filing Dt:	06/21/2012
Publication #:	US20120270882	Pub Dt:	10/25/2012
Title:	FLUORINATED DERIVATES OF 3-HYDROXYPYRIDIN-4-ONES

Patent #:	8940790	Issue Dt:	01/27/2015	Application #:	13505877	Filing Dt:	07/16/2012
Publication #:	US20120270931	Pub Dt:	10/25/2012
Title:	STABLE PHARMACEUTICAL FORMULATIONS COMPRISING LUBIPROSTONE

Patent #:	9994523	Issue Dt:	06/12/2018	Application #:	14403552	Filing Dt:	11/24/2014
Publication #:	US20150353490	Pub Dt:	12/10/2015
Title:	SALTS OF SAXAGLIPTIN WITH ORGANIC ACIDS

Patent #:	9376419	Issue Dt:	06/28/2016	Application #:	14436049	Filing Dt:	04/15/2015
Publication #:	US20150274699	Pub Dt:	10/01/2015
Title:	SOLID FORMS OF NILOTINIB HYDROCHLORIDE

Patent #:	10066001	Issue Dt:	09/04/2018	Application #:	14775248	Filing Dt:	09/11/2015
Publication #:	US20160024165	Pub Dt:	01/28/2016
Title:	ENHANCED LIQUID FORMULATION STABILITY OF ERYTHROPOIETIN ALPHA THROUGH PURIFICATION PROCESSING

Patent #:	9809551	Issue Dt:	11/07/2017	Application #:	15036137	Filing Dt:	05/12/2016
Publication #:	US20160280654	Pub Dt:	09/29/2016
Title:	SOLID FORMS OF IVACAFTOR AND PROCESSES FOR THE PREPARATION THEREOF

Patent #:	9938240	Issue Dt:	04/10/2018	Application #:	15372497	Filing Dt:	12/08/2016
Publication #:	US20170088518	Pub Dt:	03/30/2017
Title:	Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones

Patent #:	10016423	Issue Dt:	07/10/2018	Application #:	15518895	Filing Dt:	04/13/2017
Publication #:	US20170239247	Pub Dt:	08/24/2017
Title:	SOLID FORMS OF NILOTINIB HYDROCHLORIDE

Patent #:	9944616	Issue Dt:	04/17/2018	Application #:	15615020	Filing Dt:	06/06/2017
Publication #:	US20170355688	Pub Dt:	12/14/2017
Title:	Processes for the Preparation of Tasimelteon and Intermediates Thereof

Patent #:	10183024	Issue Dt:	01/22/2019	Application #:	15827471	Filing Dt:	11/30/2017
Publication #:	US20180153895	Pub Dt:	06/07/2018
Title:	Crystalline Forms of Ibrutinib

Patent #:	10301322	Issue Dt:	05/28/2019	Application #:	15850882	Filing Dt:	12/21/2017
Publication #:	US20180179226	Pub Dt:	06/28/2018
Title:	Processes for the Preparation of Edoxaban and Intermediates Thereof

Patent #:	10351537	Issue Dt:	07/16/2019	Application #:	15914165	Filing Dt:	03/07/2018
Publication #:	US20180258057	Pub Dt:	09/13/2018
Title:	Processes for the Preparation of Lesinurad and Intermediates Thereof

Patent #:	10487059	Issue Dt:	11/26/2019	Application #:	16139352	Filing Dt:	09/24/2018
Publication #:	US20190092734	Pub Dt:	03/28/2019
Title:	Crystalline Form of Eluxadoline

Patent #:	10858346	Issue Dt:	12/08/2020	Application #:	16159791	Filing Dt:	10/15/2018
Publication #:	US20190112299	Pub Dt:	04/18/2019
Title:	Crystalline Form of Lumacaftor

Patent #:	10556887	Issue Dt:	02/11/2020	Application #:	16167882	Filing Dt:	10/23/2018
Publication #:	US20190119257	Pub Dt:	04/25/2019
Title:	Processes for the Preparation of Veliparib and Intermediates Thereof

Patent #:	10407396	Issue Dt:	09/10/2019	Application #:	16185223	Filing Dt:	11/09/2018
Publication #:	US20190144397	Pub Dt:	05/16/2019
Title:	Crystalline Form of Selexipag

Patent #:	10662178	Issue Dt:	05/26/2020	Application #:	16261901	Filing Dt:	01/30/2019
Publication #:	US20190233400	Pub Dt:	08/01/2019
Title:	Crystalline Form of Olaparib

Patent #:	10513504	Issue Dt:	12/24/2019	Application #:	16294259	Filing Dt:	03/06/2019
Publication #:	US20190276424	Pub Dt:	09/12/2019
Title:	Processes for the Preparation of Apalutamide and Intermediates Thereof

Patent #:	NONE	Issue Dt:		Application #:	16304994	Filing Dt:	11/27/2018
Publication #:	US20200334921	Pub Dt:	10/22/2020
Title:	METHODS FOR PROCESS VALIDATION

Patent #:	10513500	Issue Dt:	12/24/2019	Application #:	16348720	Filing Dt:	05/09/2019
Publication #:	US20190263760	Pub Dt:	08/29/2019
Title:	Crystalline Forms of Lesinurad

Patent #:	10723739	Issue Dt:	07/28/2020	Application #:	16410137	Filing Dt:	05/13/2019
Publication #:	US20190345163	Pub Dt:	11/14/2019
Title:	Processes for the Preparation of Ribociclib and Intermediates Thereof

Patent #:	10632107	Issue Dt:	04/28/2020	Application #:	16410248	Filing Dt:	05/13/2019
Publication #:	US20190343815	Pub Dt:	11/14/2019
Title:	Crystalline Forms of Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2

Patent #:	10611772	Issue Dt:	04/07/2020	Application #:	16454200	Filing Dt:	06/27/2019
Publication #:	US20200002343	Pub Dt:	01/02/2020
Title:	Crystalline Form of Ribociclib Succinate

Patent #:	10800787	Issue Dt:	10/13/2020	Application #:	16605972	Filing Dt:	10/17/2019
Publication #:	US20200048264	Pub Dt:	02/13/2020
Title:	PROCESS FOR THE PREPARATION OF ACALABRUTINIB

Patent #:	11072620	Issue Dt:	07/27/2021	Application #:	16621183	Filing Dt:	12/10/2019
Publication #:	US20200095255	Pub Dt:	03/26/2020
Title:	Crystalline Forms of Ponatinib Hydrochloride

Patent #:	11345706	Issue Dt:	05/31/2022	Application #:	16639668	Filing Dt:	02/17/2020
Publication #:	US20210130360	Pub Dt:	05/06/2021
Title:	Crystalline Forms of Acalabrutinib

Patent #:	10822309	Issue Dt:	11/03/2020	Application #:	16683331	Filing Dt:	11/14/2019
Publication #:	US20200079740	Pub Dt:	03/12/2020
Title:	Crystalline Form of Eluxadoline

Patent #:	11220500	Issue Dt:	01/11/2022	Application #:	16718841	Filing Dt:	12/18/2019
Publication #:	US20200207761	Pub Dt:	07/02/2020
Title:	Crystalline Form of Valbenazine Dibesylate

Patent #:	10875846	Issue Dt:	12/29/2020	Application #:	16741276	Filing Dt:	01/13/2020
Publication #:	US20200223832	Pub Dt:	07/16/2020
Title:	Processes for the Preparation of Tezacaftor and Intermediates Thereof

Patent #:	11236066	Issue Dt:	02/01/2022	Application #:	16928127	Filing Dt:	07/14/2020
Publication #:	US20210017151	Pub Dt:	01/21/2021
Title:	CRYSTALLINE FORMS OF NIRAPARIB TOSYLATE

Patent #:	11440871	Issue Dt:	09/13/2022	Application #:	17095684	Filing Dt:	11/11/2020
Publication #:	US20210147338	Pub Dt:	05/20/2021
Title:	Zuclomiphene Salts and Crystalline Forms Thereof

Patent #:	11046638	Issue Dt:	06/29/2021	Application #:	17095707	Filing Dt:	11/11/2020
Publication #:	US20210147337	Pub Dt:	05/20/2021
Title:	Processes for the Preparation of Zuclomiphene and Intermediates Thereof

Patent #:	11661396	Issue Dt:	05/30/2023	Application #:	17154261	Filing Dt:	01/21/2021
Publication #:	US20210221767	Pub Dt:	07/22/2021
Title:	Crystalline Forms of Zuclomiphene Citrate

Patent #:	11667656	Issue Dt:	06/06/2023	Application #:	17159238	Filing Dt:	01/27/2021
Publication #:	US20220235079	Pub Dt:	07/28/2022
Title:	Crystalline Forms of Tenofovir Alafenamide

Patent #:	NONE	Issue Dt:		Application #:	17206362	Filing Dt:	03/19/2021
Publication #:	US20210292272	Pub Dt:	09/23/2021
Title:	Salts of Zuclomiphene

Patent #:	11578025	Issue Dt:	02/14/2023	Application #:	17503727	Filing Dt:	10/18/2021
Publication #:	US20220119331	Pub Dt:	04/21/2022
Title:	Processes for the Preparation of Zuclomiphene Intermediates

Patent #:	11377456	Issue Dt:	07/05/2022	Application #:	17601493	Filing Dt:	10/05/2021
Publication #:	US20220144866	Pub Dt:	05/12/2022
Title:	Crystalline Form of Remdesivir

Patent #:	11980622	Issue Dt:	05/14/2024	Application #:	17695881	Filing Dt:	03/16/2022
Title:	Oxcarbazepine Extended Release Dosage Form

Patent #:	NONE	Issue Dt:		Application #:	17802203	Filing Dt:	08/25/2022
Publication #:	US20240010651	Pub Dt:	01/11/2024
Title:	Processes for the Preparation of Multicomponent Crystalline Forms of Active Pharmaceutical Ingredients Using Solvent Vapour

Assignor

APOTEX INC.

Exec Dt:

04/01/2023

Assignee

THE BANK OF NOVA SCOTIA

44 KING ST WEST

TORONTO, ON, CANADA M5H1H1

Correspondence name and address
	NOREEN GOSSELIN
	KIRKLAND & ELLIS LLP
	300 NORTH LASALLE
	CHICAGO, IL 60654

Search Results as of: 06/07/2024 12:08 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6